Here, we aim to investigate in depth the potential causal link between dyslipidemia and impaired renal tubular function and to uncover the gap relating NLRP3 inflammasome activation and lipotoxicity in renal tubular cells. The gene discussed is NLRP3; the disease is metabolic syndrome.